Side-by-side comparison
LLY vs RHHBY — Side-by-side comparison
LLY screens cheaper on EV/FCF, LLY has the higher ROIC, LLY has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.
LLY
Eli Lilly & Co.
Price
$1065.00
Market cap
$737.7B
Day %
N/A
RHHBY
Roche Holding AG ADR
Price
$53.38
Market cap
$265.2B
Day %
N/A
Peer Comparison
Target stock against 1 market-cap comparable peer.
Heat map: red worst to green best
LLY implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
43.4x
FCF yield
2.3%
5Y rev CAGR
21.6%
RHHBY implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
N/A
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for LLY.
Grade C
58
/ 100
Quality Scorecard
Build-time composite score for RHHBY.
Grade F
0
/ 100